Calciphylaxis Clinical Study Expands to the United Kingdom
June 27, 2019 18:34 ET
|
Hope Pharmaceuticals
SCOTTSDALE, Ariz., June 27, 2019 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) approved a clinical trial application...
Hope Pharmaceuticals Files Supplemental New Drug Application to the Food and Drug Administration for Sodium Thiosulfate Injection
June 07, 2018 05:30 ET
|
Hope Pharmaceuticals
SCOTTSDALE, Ariz., June 07, 2018 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced that the company filed a Supplemental New Drug Application to the United States Food and Drug Administration...
First Canadian Calciphylaxis Subject to Participate in the CALISTA (Sodium Thiosulfate Injection) Clinical Study
June 05, 2018 06:30 ET
|
Hope Pharmaceuticals
SCOTTSDALE, Ariz., June 05, 2018 (GLOBE NEWSWIRE) -- Hope Pharmaceuticals today announced enrollment of the first Canadian subject to participate in the CALISTA clinical study that is evaluating...